Figure 6a shows significantly greater serum serotonin levels in BC patients than in controls (means ± SDs: 109.83 ng/mL ± 44.34) (p < 0.01 in the case of HR+HER2- and p < 0.05 in the case of HR+HER2+). The gene discussed is ERBB2; the disease is breast cancer.